Join to View Full Profile
1021 Morehead Medical DrSte ACharlotte, NC 28204
Phone+1 980-442-2000
Fax+1 919-843-9355
Dr. Paul is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2016 - 2019
University of North Carolina HospitalsResidency, Internal Medicine, 2013 - 2016
University of Miami Leonard M. Miller School of MedicineClass of 2013
Certifications & Licensure
NC State Medical License 2016 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Clinical Trials
- Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT Start of enrollment: 2020 Jul 10
Publications & Presentations
PubMed
- Enhancing risk stratification and treatment decision in multiple myeloma with SKY92 gene expression profiling in real-world data.Noa Biran, Binod Dhakal, Ruben Niesvizky, Suzanne Lentzsch, Divaya Bhutani
British Journal of Haematology. 2025-04-15 - 1 citationsMRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma.Manisha Bhutani, Myra Robinson, David Foureau, Shebli Atrash, Barry Paul
Blood Advances. 2025-02-11 - 2 citationsClinical response and pathway-specific correlates following TIGIT-LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial.Shambavi Richard, Alexander M Lesokhin, Barry Paul, Jonathan L Kaufman, Matthew Pianko
Nature Cancer. 2024-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
